Kestra Medical Technologies, Ltd. (KMTS)
NASDAQ
24.77
+0.34 (+1.39%)
Closed
Sep 21, 2026
Day's Range
24.1424.88
52 wk Range
17.3430.00
Financial Statements - KMTS - Kestra Medical Technologies, Ltd.
Revenue
95.12M▲ 59.0%
Net Income
-131.61M▼ 15.6%Net Margin -138.4%
EBITDA
-115.06M▼ 20.7%
Free Cash Flow
-117.12M▼ 15.7%
Income Statement
| Period Ending | 2026-04-30 | 2025-04-30 | 2024-04-30 | 2023-04-30 | 2021-04-30 | 2020-04-30 |
|---|---|---|---|---|---|---|
| Sales | 95.12M | 59.81M | 27.81M | 9.48M | 0 | 0 |
| Cost of Goods | 46.26M | 35.60M | 27.45M | 11.39M | - | - |
| Gross Profit | 48.86M | 24.21M | 362K | -1.91M | - | - |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | -134.74M | -106.37M | -85.06M | -44.76M | -32.70M | -29.31M |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | 2.61M | -2.76M | -2.80M | -2.76M | -38K | - |
| Pre Tax Income | -131.31M | -113.67M | -94.09M | -50.18M | -33.91M | -29.31M |
| Income Tax | 294K | 135K | 24K | 37K | 187K | 148K |
| Net Income | -131.61M | -113.81M | -94.12M | -50.21M | -34.10M | -29.46M |
| EPS Basic | - | -5.13 | -2.035801 | - | - | - |
| EPS Diluted | - | -5.13 | -2.035801 | - | - | - |
| Basic Shares Outstanding | - | 24.58M | 49.53M | - | - | - |
| Diluted Shares Outstanding | - | 24.58M | 49.53M | - | - | - |
| Ebit | -123.77M | -105.94M | -87.86M | -47.53M | -32.74M | -29.31M |
| Ebitda | -115.06M | -95.32M | -76.30M | -42.68M | -32.32M | -28.84M |
| Net Income Continuous Operations | -131.61M | -113.81M | -94.12M | -84.23M | -34.10M | -29.46M |
| Minority Interests | - | - | 692K | 0 | - | - |
| Preferred Stock Dividends | - | - | - | - | - | - |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
